Jupiter Topco LLC Invests $371.14 Million in HCA Healthcare, Inc. $HCA

Jupiter Topco LLC purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, Holdings Channel reports. The firm purchased 951,903 shares of the company’s stock, valued at approximately $371,138,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of HCA. Sumitomo Life Insurance Co. grew its stake in HCA Healthcare by 1.0% during the fourth quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after buying an additional 20 shares in the last quarter. MJP Associates Inc. ADV lifted its holdings in shares of HCA Healthcare by 2.9% during the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after acquiring an additional 21 shares during the period. Cary Street Partners Investment Advisory LLC raised its position in HCA Healthcare by 7.5% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after purchasing an additional 21 shares in the last quarter. Anchyra Partners LLC boosted its holdings in shares of HCA Healthcare by 3.7% in the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after purchasing an additional 21 shares in the last quarter. Finally, Plato Investment Management Ltd raised its holdings in shares of HCA Healthcare by 0.6% during the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after buying an additional 22 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Down 0.1%

NYSE HCA opened at $428.90 on Wednesday. The company has a market capitalization of $92.86 billion, a price-to-earnings ratio of 14.36, a PEG ratio of 1.49 and a beta of 1.10. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The stock has a fifty day simple moving average of $398.59 and a 200 day simple moving average of $442.83.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.84 earnings per share. Research analysts expect that HCA Healthcare, Inc. will post 29.42 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s payout ratio is 10.45%.

Wall Street Analyst Weigh In

Several research analysts have commented on HCA shares. Truist Financial lowered their target price on HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a research note on Monday, July 27th. Sanford C. Bernstein reissued a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. Wall Street Zen cut HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. The Goldman Sachs Group lowered their target price on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a report on Tuesday, July 28th. Finally, Mizuho lowered their price objective on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a research note on Tuesday, July 28th. Fourteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $462.64.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.